Tuesday, 6 September 2016

Pharmacovigilance 2017

About Conference

Conference Series LLC is organizing splendorous Pharmaceutical conferences welcomes you to attend the 9th International Conference and Exhibition on Pharmacovigilance  to be held during July 17-19, 2017 in Vienna, Austria. It focuses on the advancements in Pharmacovigilance, Risk Management, Drug Safety.
The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 9th International Conference and Exhibition on Pharmacovigilance  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. 
Why to attend???
With members from around the world focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Pharmacovigilance community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive named recognition at this 3-days event. World-Renowned Speakers, the most recent techniques, developments, and the newest updates in Pharmacovigilance are Hallmarks of this Conference.
Target Audience:
  • Pharmacovigilance Students, Scientists
  • Pharmacovigilance Researchers
  • Pharmacovigilance Faculty
  • Medical Colleges
  • Pharmacovigilance Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software Developing Companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

Conference Highlights

  • Pre-Clinical and Clinical Trials
  • Adverse Drug Reactions
  • Clinical Trials on Various Disorders
  • Pharmacovigilance and Risk Management
  • Drug Safety
  • Good Pharmacovigilance Practice
  • Data Quality Management and Analysis
  • Pharmacovigilance Significance & Scope
  • Diversity in Industrial Clinical Trials and Clinical Research
  • Pharmacovigilance Significance & Scope
  • Implications of BREXIT
  • Clinical Research and Statistics
  • Case Report in Clinical Trials
  • Biopharmaceutical Sciences
  • PV Data Base Management
  • PV Consultings and Bussiness Opportunity
  • Regulatory Affairs
  • Pharmacy Practices and its Challenges
  • Entrepreneurs Investment Meet

Special Issues

All accepted abstracts will be published in respective Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: http://pharmacovigilance.pharmaceuticalconferences.com/